APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Daptomycin API

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Daptomycin API Market Analysis and Forecast 2026-2032

Report ID 17398256022 January 2026192 pages

Choose your research edition.

Industry ResearchDaptomycin API Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Daptomycin API Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Daptomycin API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Daptomycin API Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Daptomycin API Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Daptomycin API market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Daptomycin API is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Daptomycin API is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Daptomycin API is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Daptomycin API is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Daptomycin API include Chongqing DaXin Pharmaceutical Co, Suzhou Pharmaceutical Technology Co, Livzon Group Fuzhou Fuxing Pharmaceutical Co, Huazhong Pharmaceutical Co, Xellia Pharmaceuticals, Tecoland Corporation, Rochem International Inc and Athos, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Daptomycin API, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Daptomycin API, also provides the sales of main regions and countries. Of the upcoming market potential for Daptomycin API, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Daptomycin API sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Daptomycin API market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Daptomycin API sales, projected growth trends, production technology, application and end-user industry.

Daptomycin API Segment by Company

Chongqing DaXin Pharmaceutical Co

Suzhou Pharmaceutical Technology Co

Livzon Group Fuzhou Fuxing Pharmaceutical Co

Huazhong Pharmaceutical Co

Xellia Pharmaceuticals

Tecoland Corporation

Rochem International Inc

Athos

Daptomycin API Segment by Type

0.99

0.98

Others

Daptomycin API Segment by Application

350mg/vial

500mg/vial

Others

Daptomycin API Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Daptomycin API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Daptomycin API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Daptomycin API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Daptomycin API in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Daptomycin API manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Daptomycin API sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Daptomycin API Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 0.99 Major Manufacturers Table 3. 0.98 Major Manufacturers Table 4. Others Major Manufacturers Table 5. Global Daptomycin API Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. 350mg/vial Major Manufacturers Table 7. 500mg/vial Major Manufacturers Table 8. Others Major Manufacturers Table 9. Daptomycin API Industry Trends Table 10. Daptomycin API Industry Drivers Table 11. Daptomycin API Industry Opportunities and Challenges Table 12. Daptomycin API Industry Restraints Table 13. Global Daptomycin API Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Daptomycin API Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Daptomycin API Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Daptomycin API Revenue Market Share by Region (2021-2026) Table 17. Global Daptomycin API Revenue Market Share by Region (2027-2032) Table 18. Global Daptomycin API Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Tons) Table 19. Global Daptomycin API Sales by Region (2021-2026) & (Tons) Table 20. Global Daptomycin API Sales by Region (2027-2032) & (Tons) Table 21. Global Daptomycin API Sales Market Share by Region (2021-2026) Table 22. Global Daptomycin API Sales Market Share by Region (2027-2032) Table 23. Global Daptomycin API Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Daptomycin API Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Daptomycin API Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Daptomycin API Sales Market Share by Manufacturers (2021-2026) Table 27. Global Daptomycin API Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 28. Global Daptomycin API Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Daptomycin API Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Daptomycin API Manufacturers, Product Type & Application Table 31. Global Daptomycin API Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Daptomycin API by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Daptomycin API Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Daptomycin API Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Daptomycin API Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Daptomycin API Revenue Market Share by Type (2021-2026) Table 38. Global Daptomycin API Revenue Market Share by Type (2027-2032) Table 39. Global Daptomycin API Sales by Type 2021 VS 2025 VS 2032 (Tons) Table 40. Global Daptomycin API Sales by Type (2021-2026) & (Tons) Table 41. Global Daptomycin API Sales by Type (2027-2032) & (Tons) Table 42. Global Daptomycin API Sales Market Share by Type (2021-2026) Table 43. Global Daptomycin API Sales Market Share by Type (2027-2032) Table 44. Global Daptomycin API Price by Type (2021-2026) & (US$/Ton) Table 45. Global Daptomycin API Price by Type (2027-2032) & (US$/Ton) Table 46. Global Daptomycin API Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Daptomycin API Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Daptomycin API Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Daptomycin API Revenue Market Share by Application (2021-2026) Table 50. Global Daptomycin API Revenue Market Share by Application (2027-2032) Table 51. Global Daptomycin API Sales by Application 2021 VS 2025 VS 2032 (Tons) Table 52. Global Daptomycin API Sales by Application (2021-2026) & (Tons) Table 53. Global Daptomycin API Sales by Application (2027-2032) & (Tons) Table 54. Global Daptomycin API Sales Market Share by Application (2021-2026) Table 55. Global Daptomycin API Sales Market Share by Application (2027-2032) Table 56. Global Daptomycin API Price by Application (2021-2026) & (US$/Ton) Table 57. Global Daptomycin API Price by Application (2027-2032) & (US$/Ton) Table 58. Chongqing DaXin Pharmaceutical Co Company Information Table 59. Chongqing DaXin Pharmaceutical Co Business Overview Table 60. Chongqing DaXin Pharmaceutical Co Daptomycin API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 61. Chongqing DaXin Pharmaceutical Co Daptomycin API Product Portfolio Table 62. Chongqing DaXin Pharmaceutical Co Recent Development Table 63. Suzhou Pharmaceutical Technology Co Company Information Table 64. Suzhou Pharmaceutical Technology Co Business Overview Table 65. Suzhou Pharmaceutical Technology Co Daptomycin API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 66. Suzhou Pharmaceutical Technology Co Daptomycin API Product Portfolio Table 67. Suzhou Pharmaceutical Technology Co Recent Development Table 68. Livzon Group Fuzhou Fuxing Pharmaceutical Co Company Information Table 69. Livzon Group Fuzhou Fuxing Pharmaceutical Co Business Overview Table 70. Livzon Group Fuzhou Fuxing Pharmaceutical Co Daptomycin API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 71. Livzon Group Fuzhou Fuxing Pharmaceutical Co Daptomycin API Product Portfolio Table 72. Livzon Group Fuzhou Fuxing Pharmaceutical Co Recent Development Table 73. Huazhong Pharmaceutical Co Company Information Table 74. Huazhong Pharmaceutical Co Business Overview Table 75. Huazhong Pharmaceutical Co Daptomycin API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 76. Huazhong Pharmaceutical Co Daptomycin API Product Portfolio Table 77. Huazhong Pharmaceutical Co Recent Development Table 78. Xellia Pharmaceuticals Company Information Table 79. Xellia Pharmaceuticals Business Overview Table 80. Xellia Pharmaceuticals Daptomycin API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 81. Xellia Pharmaceuticals Daptomycin API Product Portfolio Table 82. Xellia Pharmaceuticals Recent Development Table 83. Tecoland Corporation Company Information Table 84. Tecoland Corporation Business Overview Table 85. Tecoland Corporation Daptomycin API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 86. Tecoland Corporation Daptomycin API Product Portfolio Table 87. Tecoland Corporation Recent Development Table 88. Rochem International Inc Company Information Table 89. Rochem International Inc Business Overview Table 90. Rochem International Inc Daptomycin API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 91. Rochem International Inc Daptomycin API Product Portfolio Table 92. Rochem International Inc Recent Development Table 93. Athos Company Information Table 94. Athos Business Overview Table 95. Athos Daptomycin API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 96. Athos Daptomycin API Product Portfolio Table 97. Athos Recent Development Table 98. North America Daptomycin API Revenue by Type (2021-2026) & (US$ Million) Table 99. North America Daptomycin API Revenue by Type (2027-2032) & (US$ Million) Table 100. North America Daptomycin API Sales by Type (2021-2026) & (Tons) Table 101. North America Daptomycin API Sales by Type (2027-2032) & (Tons) Table 102. North America Daptomycin API Sales Price by Type (2021-2026) & (US$/Ton) Table 103. North America Daptomycin API Sales Price by Type (2027-2032) & (US$/Ton) Table 104. North America Daptomycin API Revenue by Application (2021-2026) & (US$ Million) Table 105. North America Daptomycin API Revenue by Application (2027-2032) & (US$ Million) Table 106. North America Daptomycin API Sales by Application (2021-2026) & (Tons) Table 107. North America Daptomycin API Sales by Application (2027-2032) & (Tons) Table 108. North America Daptomycin API Sales Price by Application (2021-2026) & (US$/Ton) Table 109. North America Daptomycin API Sales Price by Application (2027-2032) & (US$/Ton) Table 110. North America Daptomycin API Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 111. North America Daptomycin API Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 112. North America Daptomycin API Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 113. North America Daptomycin API Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 114. North America Daptomycin API Sales by Country (2021-2026) & (Tons) Table 115. North America Daptomycin API Sales by Country (2027-2032) & (Tons) Table 116. North America Daptomycin API Sales Price by Country (2021-2026) & (US$/Ton) Table 117. North America Daptomycin API Sales Price by Country (2027-2032) & (US$/Ton) Table 118. United States Daptomycin API Revenue (2021-2032) & (US$ Million) Table 119. Canada Daptomycin API Revenue (2021-2032) & (US$ Million) Table 120. Europe Daptomycin API Revenue by Type (2021-2026) & (US$ Million) Table 121. Europe Daptomycin API Revenue by Type (2027-2032) & (US$ Million) Table 122. Europe Daptomycin API Sales by Type (2021-2026) & (Tons) Table 123. Europe Daptomycin API Sales by Type (2027-2032) & (Tons) Table 124. Europe Daptomycin API Sales Price by Type (2021-2026) & (US$/Ton) Table 125. Europe Daptomycin API Sales Price by Type (2027-2032) & (US$/Ton) Table 126. Europe Daptomycin API Revenue by Application (2021-2026) & (US$ Million) Table 127. Europe Daptomycin API Revenue by Application (2027-2032) & (US$ Million) Table 128. Europe Daptomycin API Sales by Application (2021-2026) & (Tons) Table 129. Europe Daptomycin API Sales by Application (2027-2032) & (Tons) Table 130. Europe Daptomycin API Sales Price by Application (2021-2026) & (US$/Ton) Table 131. Europe Daptomycin API Sales Price by Application (2027-2032) & (US$/Ton) Table 132. Europe Daptomycin API Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 133. Europe Daptomycin API Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 134. Europe Daptomycin API Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 135. Europe Daptomycin API Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 136. Europe Daptomycin API Sales by Country (2021-2026) & (Tons) Table 137. Europe Daptomycin API Sales by Country (2027-2032) & (Tons) Table 138. Europe Daptomycin API Sales Price by Country (2021-2026) & (US$/Ton) Table 139. Europe Daptomycin API Sales Price by Country (2027-2032) & (US$/Ton) Table 140. Germany Daptomycin API Revenue (2021-2032) & (US$ Million) Table 141. France Daptomycin API Revenue (2021-2032) & (US$ Million) Table 142. U.K. Daptomycin API Revenue (2021-2032) & (US$ Million) Table 143. Italy Daptomycin API Revenue (2021-2032) & (US$ Million) Table 144. Netherlands Daptomycin API Revenue (2021-2032) & (US$ Million) Table 145. China Daptomycin API Revenue by Type (2021-2026) & (US$ Million) Table 146. China Daptomycin API Revenue by Type (2027-2032) & (US$ Million) Table 147. China Daptomycin API Sales by Type (2021-2026) & (Tons) Table 148. China Daptomycin API Sales by Type (2027-2032) & (Tons) Table 149. China Daptomycin API Sales Price by Type (2021-2026) & (US$/Ton) Table 150. China Daptomycin API Sales Price by Type (2027-2032) & (US$/Ton) Table 151. China Daptomycin API Revenue by Application (2021-2026) & (US$ Million) Table 152. China Daptomycin API Revenue by Application (2027-2032) & (US$ Million) Table 153. China Daptomycin API Sales by Application (2021-2026) & (Tons) Table 154. China Daptomycin API Sales by Application (2027-2032) & (Tons) Table 155. China Daptomycin API Sales Price by Application (2021-2026) & (US$/Ton) Table 156. China Daptomycin API Sales Price by Application (2027-2032) & (US$/Ton) Table 157. Asia Daptomycin API Revenue by Type (2021-2026) & (US$ Million) Table 158. Asia Daptomycin API Revenue by Type (2027-2032) & (US$ Million) Table 159. Asia Daptomycin API Sales by Type (2021-2026) & (Tons) Table 160. Asia Daptomycin API Sales by Type (2027-2032) & (Tons) Table 161. Asia Daptomycin API Sales Price by Type (2021-2026) & (US$/Ton) Table 162. Asia Daptomycin API Sales Price by Type (2027-2032) & (US$/Ton) Table 163. Asia Daptomycin API Revenue by Application (2021-2026) & (US$ Million) Table 164. Asia Daptomycin API Revenue by Application (2027-2032) & (US$ Million) Table 165. Asia Daptomycin API Sales by Application (2021-2026) & (Tons) Table 166. Asia Daptomycin API Sales by Application (2027-2032) & (Tons) Table 167. Asia Daptomycin API Sales Price by Application (2021-2026) & (US$/Ton) Table 168. Asia Daptomycin API Sales Price by Application (2027-2032) & (US$/Ton) Table 169. Asia Daptomycin API Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 170. Asia Daptomycin API Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 171. Asia Daptomycin API Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 172. Asia Daptomycin API Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 173. Asia Daptomycin API Sales by Country (2021-2026) & (Tons) Table 174. Asia Daptomycin API Sales by Country (2027-2032) & (Tons) Table 175. Asia Daptomycin API Sales Price by Country (2021-2026) & (US$/Ton) Table 176. Asia Daptomycin API Sales Price by Country (2027-2032) & (US$/Ton) Table 177. Japan Daptomycin API Revenue (2021-2032) & (US$ Million) Table 178. South Korea Daptomycin API Revenue (2021-2032) & (US$ Million) Table 179. India Daptomycin API Revenue (2021-2032) & (US$ Million) Table 180. Australia Daptomycin API Revenue (2021-2032) & (US$ Million) Table 181. China Taiwan Daptomycin API Revenue (2021-2032) & (US$ Million) Table 182. Southeast Asia Daptomycin API Revenue (2021-2032) & (US$ Million) Table 183. SAMEA Daptomycin API Revenue by Type (2021-2026) & (US$ Million) Table 184. SAMEA Daptomycin API Revenue by Type (2027-2032) & (US$ Million) Table 185. SAMEA Daptomycin API Sales by Type (2021-2026) & (Tons) Table 186. SAMEA Daptomycin API Sales by Type (2027-2032) & (Tons) Table 187. SAMEA Daptomycin API Sales Price by Type (2021-2026) & (US$/Ton) Table 188. SAMEA Daptomycin API Sales Price by Type (2027-2032) & (US$/Ton) Table 189. SAMEA Daptomycin API Revenue by Application (2021-2026) & (US$ Million) Table 190. SAMEA Daptomycin API Revenue by Application (2027-2032) & (US$ Million) Table 191. SAMEA Daptomycin API Sales by Application (2021-2026) & (Tons) Table 192. SAMEA Daptomycin API Sales by Application (2027-2032) & (Tons) Table 193. SAMEA Daptomycin API Sales Price by Application (2021-2026) & (US$/Ton) Table 194. SAMEA Daptomycin API Sales Price by Application (2027-2032) & (US$/Ton) Table 195. SAMEA Daptomycin API Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 196. SAMEA Daptomycin API Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 197. SAMEA Daptomycin API Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 198. SAMEA Daptomycin API Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 199. SAMEA Daptomycin API Sales by Country (2021-2026) & (Tons) Table 200. SAMEA Daptomycin API Sales by Country (2027-2032) & (Tons) Table 201. SAMEA Daptomycin API Sales Price by Country (2021-2026) & (US$/Ton) Table 202. SAMEA Daptomycin API Sales Price by Country (2027-2032) & (US$/Ton) Table 203. Brazil Daptomycin API Revenue (2021-2032) & (US$ Million) Table 204. Argentina Daptomycin API Revenue (2021-2032) & (US$ Million) Table 205. Chile Daptomycin API Revenue (2021-2032) & (US$ Million) Table 206. Colombia Daptomycin API Revenue (2021-2032) & (US$ Million) Table 207. Peru Daptomycin API Revenue (2021-2032) & (US$ Million) Table 208. Saudi Arabia Daptomycin API Revenue (2021-2032) & (US$ Million) Table 209. Israel Daptomycin API Revenue (2021-2032) & (US$ Million) Table 210. UAE Daptomycin API Revenue (2021-2032) & (US$ Million) Table 211. Turkey Daptomycin API Revenue (2021-2032) & (US$ Million) Table 212. Iran Daptomycin API Revenue (2021-2032) & (US$ Million) Table 213. Egypt Daptomycin API Revenue (2021-2032) & (US$ Million) Table 214. Key Raw Materials Table 215. Raw Materials Key Suppliers Table 216. Daptomycin API Distributors List Table 217. Daptomycin API Customers List Table 218. Research Programs/Design for This Report Table 219. Authors List of This Report Table 220. Secondary Sources Table 221. Primary Sources List of Figures Figure 1. Daptomycin API Image Figure 2. Global Daptomycin API Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Daptomycin API Market Size Share 2021 VS 2025 VS 2032 Figure 4. 0.99 Image Figure 5. 0.98 Image Figure 6. Others Image Figure 7. Global Daptomycin API Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Daptomycin API Market Size Share 2021 VS 2025 VS 2032 Figure 9. 350mg/vial Image Figure 10. 500mg/vial Image Figure 11. Others Image Figure 12. Global Daptomycin API Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Daptomycin API Revenue (2021-2032) & (US$ Million) Figure 14. Global Daptomycin API Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Daptomycin API Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Daptomycin API Revenue Market Share by Region (2021-2032) Figure 17. Global Daptomycin API Sales (2021-2032) & (Tons) Figure 18. Global Daptomycin API Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 19. Global Daptomycin API Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Daptomycin API Sales YoY (2021-2032) & (Tons) Figure 21. Europe Daptomycin API Sales YoY (2021-2032) & (Tons) Figure 22. China Daptomycin API Sales YoY (2021-2032) & (Tons) Figure 23. Asia (Excluding China) Daptomycin API Sales YoY (2021-2032) & (Tons) Figure 24. South America, Middle East and Africa Daptomycin API Sales YoY (2021-2032) & (Tons) Figure 25. Global Daptomycin API Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Daptomycin API Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Daptomycin API Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Daptomycin API Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Daptomycin API Revenue Market Share by Type (2021-2032) Figure 31. Global Daptomycin API Sales by Type (2021 VS 2025 VS 2032) & (Tons) Figure 32. Global Daptomycin API Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Daptomycin API Sales Market Share by Type (2021-2032) Figure 34. Global Daptomycin API Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Daptomycin API Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Daptomycin API Revenue Market Share by Application (2021-2032) Figure 37. Global Daptomycin API Sales by Application (2021 VS 2025 VS 2032) & (Tons) Figure 38. Global Daptomycin API Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Daptomycin API Sales Market Share by Application (2021-2032) Figure 40. North America Daptomycin API Revenue Share by Type (2021-2032) Figure 41. North America Daptomycin API Sales Share by Type (2021-2032) Figure 42. North America Daptomycin API Revenue Share by Application (2021-2032) Figure 43. North America Daptomycin API Sales Share by Application (2021-2032) Figure 44. North America Daptomycin API Revenue Share by Country (2021-2032) Figure 45. North America Daptomycin API Sales Share by Country (2021-2032) Figure 46. Europe Daptomycin API Revenue Share by Type (2021-2032) Figure 47. Europe Daptomycin API Sales Share by Type (2021-2032) Figure 48. Europe Daptomycin API Revenue Share by Application (2021-2032) Figure 49. Europe Daptomycin API Sales Share by Application (2021-2032) Figure 50. Europe Daptomycin API Revenue Share by Country (2021-2032) Figure 51. Europe Daptomycin API Sales Share by Country (2021-2032) Figure 52. China Daptomycin API Revenue Share by Type (2021-2032) Figure 53. China Daptomycin API Sales Share by Type (2021-2032) Figure 54. China Daptomycin API Revenue Share by Application (2021-2032) Figure 55. China Daptomycin API Sales Share by Application (2021-2032) Figure 56. Asia Daptomycin API Revenue Share by Type (2021-2032) Figure 57. Asia Daptomycin API Sales Share by Type (2021-2032) Figure 58. Asia Daptomycin API Revenue Share by Application (2021-2032) Figure 59. Asia Daptomycin API Sales Share by Application (2021-2032) Figure 60. Asia Daptomycin API Revenue Share by Country (2021-2032) Figure 61. Asia Daptomycin API Sales Share by Country (2021-2032) Figure 62. SAMEA Daptomycin API Revenue Share by Type (2021-2032) Figure 63. SAMEA Daptomycin API Sales Share by Type (2021-2032) Figure 64. SAMEA Daptomycin API Revenue Share by Application (2021-2032) Figure 65. SAMEA Daptomycin API Sales Share by Application (2021-2032) Figure 66. SAMEA Daptomycin API Revenue Share by Country (2021-2032) Figure 67. SAMEA Daptomycin API Sales Share by Country (2021-2032) Figure 68. Daptomycin API Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Daptomycin API Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 0.99
  • 0.98
  • Others
Applications
  • 350mg/vial
  • 500mg/vial
  • Others
Companies covered
  • Chongqing DaXin Pharmaceutical Co
  • Suzhou Pharmaceutical Technology Co
  • Livzon Group Fuzhou Fuxing Pharmaceutical Co
  • Huazhong Pharmaceutical Co
  • Xellia Pharmaceuticals
  • Tecoland Corporation
  • Rochem International Inc
  • Athos

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Daptomycin API Market by Type
  3. 1.2.1 Global Daptomycin API Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 0.99
  5. 1.2.3 0.98
  6. 1.2.4 Others
  7. 1.3 Daptomycin API Market by Application
  8. 1.3.1 Global Daptomycin API Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 350mg/vial
  10. 1.3.3 500mg/vial
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Daptomycin API Market Dynamics
  1. 2.1 Daptomycin API Industry Trends
  2. 2.2 Daptomycin API Industry Drivers
  3. 2.3 Daptomycin API Industry Opportunities and Challenges
  4. 2.4 Daptomycin API Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Daptomycin API Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Daptomycin API Revenue by Region
  3. 3.2.1 Global Daptomycin API Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Daptomycin API Revenue by Region (2021-2026)
  5. 3.2.3 Global Daptomycin API Revenue by Region (2027-2032)
  6. 3.2.4 Global Daptomycin API Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Daptomycin API Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Daptomycin API Sales by Region
  9. 3.4.1 Global Daptomycin API Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Daptomycin API Sales by Region (2021-2026)
  11. 3.4.3 Global Daptomycin API Sales by Region (2027-2032)
  12. 3.4.4 Global Daptomycin API Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Daptomycin API Revenue by Manufacturers
  2. 4.1.1 Global Daptomycin API Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Daptomycin API Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Daptomycin API Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Daptomycin API Sales by Manufacturers
  6. 4.2.1 Global Daptomycin API Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Daptomycin API Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Daptomycin API Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Daptomycin API Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Daptomycin API Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Daptomycin API Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Daptomycin API Manufacturers, Product Type & Application
  13. 4.7 Global Daptomycin API Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Daptomycin API Market CR5 and HHI
  16. 4.8.2 2025 Daptomycin API Tier 1, Tier 2, and Tier 3
5 Daptomycin API Market by Type
  1. 5.1 Global Daptomycin API Revenue by Type
  2. 5.1.1 Global Daptomycin API Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Daptomycin API Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Daptomycin API Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Daptomycin API Sales by Type
  6. 5.2.1 Global Daptomycin API Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Daptomycin API Sales by Type (2021-2032) & (Tons)
  8. 5.2.3 Global Daptomycin API Sales Market Share by Type (2021-2032)
  9. 5.3 Global Daptomycin API Price by Type
6 Daptomycin API Market by Application
  1. 6.1 Global Daptomycin API Revenue by Application
  2. 6.1.1 Global Daptomycin API Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Daptomycin API Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Daptomycin API Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Daptomycin API Sales by Application
  6. 6.2.1 Global Daptomycin API Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Daptomycin API Sales by Application (2021-2032) & (Tons)
  8. 6.2.3 Global Daptomycin API Sales Market Share by Application (2021-2032)
  9. 6.3 Global Daptomycin API Price by Application
7 Company Profiles
  1. 7.1 Chongqing DaXin Pharmaceutical Co
  2. 7.1.1 Chongqing DaXin Pharmaceutical Co Company Information
  3. 7.1.2 Chongqing DaXin Pharmaceutical Co Business Overview
  4. 7.1.3 Chongqing DaXin Pharmaceutical Co Daptomycin API Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Chongqing DaXin Pharmaceutical Co Daptomycin API Product Portfolio
  6. 7.1.5 Chongqing DaXin Pharmaceutical Co Recent Developments
  7. 7.2 Suzhou Pharmaceutical Technology Co
  8. 7.2.1 Suzhou Pharmaceutical Technology Co Company Information
  9. 7.2.2 Suzhou Pharmaceutical Technology Co Business Overview
  10. 7.2.3 Suzhou Pharmaceutical Technology Co Daptomycin API Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Suzhou Pharmaceutical Technology Co Daptomycin API Product Portfolio
  12. 7.2.5 Suzhou Pharmaceutical Technology Co Recent Developments
  13. 7.3 Livzon Group Fuzhou Fuxing Pharmaceutical Co
  14. 7.3.1 Livzon Group Fuzhou Fuxing Pharmaceutical Co Company Information
  15. 7.3.2 Livzon Group Fuzhou Fuxing Pharmaceutical Co Business Overview
  16. 7.3.3 Livzon Group Fuzhou Fuxing Pharmaceutical Co Daptomycin API Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Livzon Group Fuzhou Fuxing Pharmaceutical Co Daptomycin API Product Portfolio
  18. 7.3.5 Livzon Group Fuzhou Fuxing Pharmaceutical Co Recent Developments
  19. 7.4 Huazhong Pharmaceutical Co
  20. 7.4.1 Huazhong Pharmaceutical Co Company Information
  21. 7.4.2 Huazhong Pharmaceutical Co Business Overview
  22. 7.4.3 Huazhong Pharmaceutical Co Daptomycin API Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Huazhong Pharmaceutical Co Daptomycin API Product Portfolio
  24. 7.4.5 Huazhong Pharmaceutical Co Recent Developments
  25. 7.5 Xellia Pharmaceuticals
  26. 7.5.1 Xellia Pharmaceuticals Company Information
  27. 7.5.2 Xellia Pharmaceuticals Business Overview
  28. 7.5.3 Xellia Pharmaceuticals Daptomycin API Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Xellia Pharmaceuticals Daptomycin API Product Portfolio
  30. 7.5.5 Xellia Pharmaceuticals Recent Developments
  31. 7.6 Tecoland Corporation
  32. 7.6.1 Tecoland Corporation Company Information
  33. 7.6.2 Tecoland Corporation Business Overview
  34. 7.6.3 Tecoland Corporation Daptomycin API Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Tecoland Corporation Daptomycin API Product Portfolio
  36. 7.6.5 Tecoland Corporation Recent Developments
  37. 7.7 Rochem International Inc
  38. 7.7.1 Rochem International Inc Company Information
  39. 7.7.2 Rochem International Inc Business Overview
  40. 7.7.3 Rochem International Inc Daptomycin API Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Rochem International Inc Daptomycin API Product Portfolio
  42. 7.7.5 Rochem International Inc Recent Developments
  43. 7.8 Athos
  44. 7.8.1 Athos Company Information
  45. 7.8.2 Athos Business Overview
  46. 7.8.3 Athos Daptomycin API Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Athos Daptomycin API Product Portfolio
  48. 7.8.5 Athos Recent Developments
8 North America
  1. 8.1 North America Daptomycin API Market Size by Type
  2. 8.1.1 North America Daptomycin API Revenue by Type (2021-2032)
  3. 8.1.2 North America Daptomycin API Sales by Type (2021-2032)
  4. 8.1.3 North America Daptomycin API Price by Type (2021-2032)
  5. 8.2 North America Daptomycin API Market Size by Application
  6. 8.2.1 North America Daptomycin API Revenue by Application (2021-2032)
  7. 8.2.2 North America Daptomycin API Sales by Application (2021-2032)
  8. 8.2.3 North America Daptomycin API Price by Application (2021-2032)
  9. 8.3 North America Daptomycin API Market Size by Country
  10. 8.3.1 North America Daptomycin API Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Daptomycin API Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Daptomycin API Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Daptomycin API Market Size by Type
  2. 9.1.1 Europe Daptomycin API Revenue by Type (2021-2032)
  3. 9.1.2 Europe Daptomycin API Sales by Type (2021-2032)
  4. 9.1.3 Europe Daptomycin API Price by Type (2021-2032)
  5. 9.2 Europe Daptomycin API Market Size by Application
  6. 9.2.1 Europe Daptomycin API Revenue by Application (2021-2032)
  7. 9.2.2 Europe Daptomycin API Sales by Application (2021-2032)
  8. 9.2.3 Europe Daptomycin API Price by Application (2021-2032)
  9. 9.3 Europe Daptomycin API Market Size by Country
  10. 9.3.1 Europe Daptomycin API Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Daptomycin API Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Daptomycin API Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Daptomycin API Market Size by Type
  2. 10.1.1 China Daptomycin API Revenue by Type (2021-2032)
  3. 10.1.2 China Daptomycin API Sales by Type (2021-2032)
  4. 10.1.3 China Daptomycin API Price by Type (2021-2032)
  5. 10.2 China Daptomycin API Market Size by Application
  6. 10.2.1 China Daptomycin API Revenue by Application (2021-2032)
  7. 10.2.2 China Daptomycin API Sales by Application (2021-2032)
  8. 10.2.3 China Daptomycin API Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Daptomycin API Market Size by Type
  2. 11.1.1 Asia Daptomycin API Revenue by Type (2021-2032)
  3. 11.1.2 Asia Daptomycin API Sales by Type (2021-2032)
  4. 11.1.3 Asia Daptomycin API Price by Type (2021-2032)
  5. 11.2 Asia Daptomycin API Market Size by Application
  6. 11.2.1 Asia Daptomycin API Revenue by Application (2021-2032)
  7. 11.2.2 Asia Daptomycin API Sales by Application (2021-2032)
  8. 11.2.3 Asia Daptomycin API Price by Application (2021-2032)
  9. 11.3 Asia Daptomycin API Market Size by Country
  10. 11.3.1 Asia Daptomycin API Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Daptomycin API Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Daptomycin API Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Daptomycin API Market Size by Type
  2. 12.1.1 SAMEA Daptomycin API Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Daptomycin API Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Daptomycin API Price by Type (2021-2032)
  5. 12.2 SAMEA Daptomycin API Market Size by Application
  6. 12.2.1 SAMEA Daptomycin API Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Daptomycin API Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Daptomycin API Price by Application (2021-2032)
  9. 12.3 SAMEA Daptomycin API Market Size by Country
  10. 12.3.1 SAMEA Daptomycin API Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Daptomycin API Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Daptomycin API Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Daptomycin API Value Chain Analysis
  2. 13.1.1 Daptomycin API Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Daptomycin API Production Mode & Process
  6. 13.2 Daptomycin API Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Daptomycin API Distributors
  9. 13.2.3 Daptomycin API Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst